Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Renard

Showing results (181-190 of 225) with videos related to

Pageof 23
Sort By:
Diabetes Care|May 22, 2016
Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at HomeEric Renard, Anne Farret, Jort Kropff, et al.
Diabetes, Obesity & Metabolism|December 2, 2025
Severity of complications is associated with impaired health-related quality of life in people with type 1 diabetesSara Barraud, Gloria A Aguayo, Emmanuel Cosson, et al.
The Lancet. Diabetes & Endocrinology|October 4, 2015
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trialJort Kropff, Simone Del Favero, Jerome Place, et al.
Journal of Clinical Medicine|July 26, 2020
The Plasmatic Aldosterone and C-Reactive Protein Levels, and the Severity of Covid-19: The Dyhor-19 StudyOrianne Villard, David Morquin, Nicolas Molinari, et al.
Diabetes Care|March 30, 2012
Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter studyJean-Pierre Riveline, Pauline Schaepelynck, Lucy Chaillous, et al.
The Lancet. Diabetes & Endocrinology|April 27, 2020
Practical recommendations for the management of diabetes in patients with COVID-19Stefan R Bornstein, Francesco Rubino, Kamlesh Khunti, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 18, 2024
Associations of clinical, psychological, and sociodemographic characteristics and ecological momentary assessment completion in the 10-week Hypo-METRICS study: Hypoglycaemia MEasurements ThResholds and ImpaCtSNatalie Zaremba, Gilberte Martine-Edith, Patrick Divilly, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 31, 2025
User evaluation of the Hypo-METRICS app: A tool for real-time symptom reporting of hypoglycaemiaMonika Cigler, Uffe Søholm, Melanie Broadley, et al.
Diabetes Technology & Therapeutics|March 17, 2023
Hybrid Closed Loop Overcomes the Impact of Missed or Suboptimal Meal Boluses on Glucose Control in Children with Type 1 Diabetes Compared to Sensor-Augmented Pump TherapyRégis Coutant, Elise Bismuth, Elisabeth Bonnemaison, et al.
Diabetes Care|August 29, 2024
Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS StudyPatrick Divilly, Gilberte Martine-Edith, Natalie Zaremba, et al.
Pageof 23

Showing results (181-190 of 225) with videos related to

Sort By:
Pageof 23
Diabetes Care|May 22, 2016
Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at HomeEric Renard, Anne Farret, Jort Kropff, et al.
Diabetes, Obesity & Metabolism|December 2, 2025
Severity of complications is associated with impaired health-related quality of life in people with type 1 diabetesSara Barraud, Gloria A Aguayo, Emmanuel Cosson, et al.
The Lancet. Diabetes & Endocrinology|October 4, 2015
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trialJort Kropff, Simone Del Favero, Jerome Place, et al.
Journal of Clinical Medicine|July 26, 2020
The Plasmatic Aldosterone and C-Reactive Protein Levels, and the Severity of Covid-19: The Dyhor-19 StudyOrianne Villard, David Morquin, Nicolas Molinari, et al.
Diabetes Care|March 30, 2012
Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter studyJean-Pierre Riveline, Pauline Schaepelynck, Lucy Chaillous, et al.
The Lancet. Diabetes & Endocrinology|April 27, 2020
Practical recommendations for the management of diabetes in patients with COVID-19Stefan R Bornstein, Francesco Rubino, Kamlesh Khunti, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 18, 2024
Associations of clinical, psychological, and sociodemographic characteristics and ecological momentary assessment completion in the 10-week Hypo-METRICS study: Hypoglycaemia MEasurements ThResholds and ImpaCtSNatalie Zaremba, Gilberte Martine-Edith, Patrick Divilly, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 31, 2025
User evaluation of the Hypo-METRICS app: A tool for real-time symptom reporting of hypoglycaemiaMonika Cigler, Uffe Søholm, Melanie Broadley, et al.
Diabetes Technology & Therapeutics|March 17, 2023
Hybrid Closed Loop Overcomes the Impact of Missed or Suboptimal Meal Boluses on Glucose Control in Children with Type 1 Diabetes Compared to Sensor-Augmented Pump TherapyRégis Coutant, Elise Bismuth, Elisabeth Bonnemaison, et al.
Diabetes Care|August 29, 2024
Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS StudyPatrick Divilly, Gilberte Martine-Edith, Natalie Zaremba, et al.
Pageof 23